Luteinizing hormone-releasing hormone analogues in early breast cancer: updated status of ongoing clinical trials.
Open Access
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (4) , 9-11
- https://doi.org/10.1038/bjc.1998.755
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Present and future projects of the international breast cancer study groupCancer, 1994
- Survival data relating to the use of goserelin depot in the treatment of premenopausal advanced breast cancerEuropean Journal Of Cancer, 1993
- Goserelin depot in the treatment of premenopausal advanced breast cancerEuropean Journal Of Cancer, 1992
- Clinical trials referral resource. Breast cancer.1991
- The Depot GnRH Analogue Goserelin in the Treatment of Premenopausal Patients with Metastatic Breast Cancer -A 5-Year Experience and further Endocrine TherapiesOncology Research and Treatment, 1991
- Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.Journal of Clinical Oncology, 1989